Amrize Ltd $AMRZ Shares Sold by Vontobel Holding Ltd.

Key Points

• Vontobel Holding reduced its Amrize stake by 7.3%, selling 348,602 shares during the third quarter and retaining 4.45 million shares valued at approximately $167 million.
• Analyst sentiment is mixed, with Amrize receiving a consensus “Hold” rating and an average price target of $50. Several firms recently lowered their targets, while Longbow Research initiated coverage with a “Buy” rating.
• Amrize shares traded at $37.85, near their 52-week low of $35.78, after the company slightly missed quarterly EPS expectations. The company also paid a $0.11 dividend, while insiders purchased nearly 49,000 shares over the past 90 days.

Vontobel Holding Ltd. lessened its stake in shares of Amrize Ltd (NYSE:AMRZ - Free Report) by 7.3% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 4,447,467 shares of the company's stock after selling 348,602 shares during the quarter. Vontobel Holding Ltd. owned 0.80% of Amrize worth $166,965,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently modified their holdings of AMRZ. Pictet Asset Management Holding SA raised its holdings in shares of Amrize by 4.7% during the 1st quarter. Pictet Asset Management Holding SA now owns 5,216,765 shares of the company's stock valued at $283,017,000 after buying an additional 234,731 shares during the period. Allspring Global Investments Holdings LLC grew its stake in Amrize by 3.7% in the first quarter. Allspring Global Investments Holdings LLC now owns 4,772,941 shares of the company's stock worth $263,371,000 after purchasing an additional 171,622 shares in the last quarter. River Road Asset Management LLC increased its holdings in shares of Amrize by 26.1% in the 4th quarter. River Road Asset Management LLC now owns 2,883,536 shares of the company's stock valued at $155,942,000 after acquiring an additional 597,542 shares during the last quarter. Renaissance Technologies LLC boosted its holdings in shares of Amrize by 10.4% in the 1st quarter. Renaissance Technologies LLC now owns 1,956,600 shares of the company's stock valued at $109,609,000 after buying an additional 183,900 shares during the period. Finally, Amundi boosted its stake in Amrize by 30.9% in the first quarter. Amundi now owns 1,654,739 shares of the company's stock valued at $92,698,000 after acquiring an additional 390,750 shares during the period.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on AMRZ. Zacks Research downgraded Amrize from a "hold" rating to a "strong sell" rating in a research report on Wednesday, August 19th. Deutsche Bank Aktiengesellschaft cut their target price on Amrize from $64.00 to $56.00 and set a "buy" rating on the stock in a research report on Wednesday, September 23rd. Longbow Research assumed coverage on Amrize in a report on Monday, October 12th. They issued a "buy" rating for the company. Royal Bank Of Canada reduced their price objective on Amrize from $48.00 to $32.00 and set an "underperform" rating for the company in a research report on Friday, October 9th. Finally, JPMorgan Chase & Co. reduced their target price on Amrize from $52.00 to $48.00 and set a "neutral" rating for the company in a report on Tuesday. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, seven have issued a Hold rating and four have given a Sell rating to the company. According to MarketBeat.com, Amrize currently has a consensus rating of "Hold" and an average price target of $50.00.

Amrize Price Performance

Shares of NYSE AMRZ traded up $0.54 during trading on Friday, reaching $37.85. The company had a trading volume of 4,542,880 shares, compared to its average volume of 3,589,370. The business's 50 day moving average price is $40.94 and its 200-day moving average price is $48.83. Amrize Ltd has a 52 week low of $35.78 and a 52 week high of $65.94. The company has a debt-to-equity ratio of 0.33, a quick ratio of 0.73 and a current ratio of 1.10. The stock has a market cap of $20.94 billion, a PE ratio of 17.44, a PEG ratio of 1.32 and a beta of 0.20.

Amrize (NYSE:AMRZ - Get Free Report) last issued its earnings results on Thursday, August 6th. The company reported $0.88 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.92 by ($0.04). The business had revenue of $3.49 billion during the quarter. Amrize had a net margin of 9.89% and a return on equity of 10.22%. Analysts expect that Amrize Ltd will post 2.44 earnings per share for the current year.

Amrize Announces Dividend

The firm also recently disclosed a dividend, which was paid on Wednesday, August 26th. Stockholders of record on Tuesday, August 18th were given a $0.11 dividend. The ex-dividend date of this dividend was Tuesday, August 18th. Amrize's payout ratio is currently 5.07%.

Insider Activity at Amrize

In other news, CFO Baris Oran bought 3,000 shares of the stock in a transaction that occurred on Tuesday, August 11th. The shares were acquired at an average cost of $47.38 per share, for a total transaction of $142,140.00. Following the completion of the acquisition, the chief financial officer owned 3,000 shares in the company, valued at approximately $142,140. This represents a ∞ increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Mario Gross acquired 3,568 shares of the company's stock in a transaction on Tuesday, August 11th. The stock was acquired at an average price of $46.60 per share, for a total transaction of $166,268.80. Following the purchase, the insider directly owned 38,485 shares of the company's stock, valued at approximately $1,793,401. This trade represents a 10.22% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Over the last 90 days, insiders acquired 48,983 shares of company stock worth $2,158,755. Corporate insiders own 0.54% of the company's stock.

Amrize Company Profile

Amrize Ltd. is a North American building solutions company that produces and supplies essential construction materials and related products. Its portfolio includes cement, aggregates, ready-mix concrete, asphalt, concrete products and roofing systems used in residential, commercial and infrastructure projects.

The company serves customers across the United States and Canada through a network of production facilities, distribution locations and other operating sites. Its products support a range of construction applications, including roads, bridges, buildings, homes and other major infrastructure.

Amrize was established as the result of the separation of Holcim's North American business and began operating as an independent, publicly traded company in 2025.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.